7 results on '"Jean, Sonia"'
Search Results
2. Exploring polypharmacy with artificial intelligence: data analysis protocol
- Author
-
Sirois, Caroline, Khoury, Richard, Durand, Audrey, Deziel, Pierre-Luc, Bukhtiyarova, Olga, Chiu, Yohann, Talbot, Denis, Bureau, Alexandre, Després, Philippe, Gagné, Christian, Laviolette, François, Savard, Anne-Marie, Corbeil, Jacques, Badard, Thierry, Jean, Sonia, and Simard, Marc
- Published
- 2021
- Full Text
- View/download PDF
3. Frailty and health services use among Quebec seniors with non-hip fractures: a population-based study using adminsitrative databases
- Author
-
Fillion, Vanessa, Sirois, Marie-Josée, Gamache, Philippe, Guertin, Jason Robert, Morin, Suzanne N., and Jean, Sonia
- Published
- 2019
- Full Text
- View/download PDF
4. Fracture risk in dialysis and kidney transplanted patients: a protocol for systematic review and meta-analysis.
- Author
-
Sidibé, Aboubacar, Moore, Lynne, Jean, Sonia, and Mac-Way, Fabrice
- Subjects
KIDNEY transplantation ,HEMODIALYSIS ,CARDIOVASCULAR disease related mortality - Abstract
Background: Chronic kidney disease (CKD) is associated with an increased risk of fracture and cardiovascular mortality. The risk of fracture in hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT) is higher when compared to the general population. However, uncertainties remain about which group has the highest risk of fracture. We aim to identify the risk of fracture and cardiovascular mortality post-fracture in HD compared to PD or KT and in PD compared to KT population. Methods: We will conduct a systematic review of observational studies and randomized control trials on patients with CKD. Eligible studies will be searched on MEDLINE, Embase, Web of Science, Cochrane Library, and in gray literature. Two independent reviewers will screen all identified references in order to include studies reporting the risk of fracture without a comparator or comparing that risk in HD vs KT, PD vs KT, or HD vs PD. Studies comparing the risk of fracture in a renal replacement therapy group to general population or to non-dialyzed CKD patients will also be included. Data on study settings, population characteristics, intervention, comparator, and outcomes will be extracted. Study data will be summarized and analyzed in RevMan and SAS. Risk of bias in cohort design studies will be assessed with an adapted version of the ROBINS-I tool and by the Cochrane handbook tool for RCTs. The quality of evidence and strengths of recommendations will be evaluated by the Grading of Recommendations Assessment, Development and Evaluations (GRADE) tool. We will pool relative risks with random-effect models and Mantel-Haenszel methods. Subgroup and sensitive analysis are planned according to the intervention and comparator, study design, and type of fracture. Discussion: This review will provide new pooled data about fracture risk in dialysis and KT patients. Our results should guide the implementation of future preventive strategies targeting patients with the highest fracture risk. A pooled analysis of observational studies could be limited by a probable considerable heterogeneity among these studies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Rheumatoid arthritis prevalence in Quebec.
- Author
-
Bernatsky, Sasha, Dekis, Alaa, Hudson, Marie, Pineau, Christian A., Boire, Gilles, Fortin, Paul R., Bessette, Louis, Jean, Sonia, Chetaille, Ann L., Belisle, Patrick, Bergeron, Louise, Ehrmann Feldman, Debbie, and Joseph, Lawrence
- Subjects
DISEASE prevalence ,RHEUMATOID arthritis diagnosis ,EPIDEMIOLOGY ,RHEUMATOID arthritis treatment ,PUBLIC health - Abstract
Background To estimate rheumatoid arthritis (RA) prevalence in Quebec using administrative health data, comparing across regions. Methods Cases of RA were ascertained from physician billing and hospitalization data, 1992-2008. We used three case definitions: 1) ≥ 2 billing diagnoses, submitted by any physician, ≥ 2 months apart, but within 2 years; 2) ≥ 1 diagnosis, by a rheumatologist; 3) ≥1 hospitalization diagnosis (all based on ICD-9 code 714, and ICD-10 code M05). We combined data across these three case definitions, using Bayesian hierarchical latent class models to estimate RA prevalence, adjusting for the imperfect sensitivity and specificity of the data. We compared urban versus rural regions. Results Using our case definitions and no adjustment for error, we defined 75,760 cases for an overall RA prevalence of 9.9 per thousand residents. After adjusting for the imperfect sensitivity and specificity of our case definition algorithms, we estimated Quebec RA prevalence at 5.6 per 1000 females and 4.1 per 1000 males. The adjusted RA prevalence estimates for older females were the highest for any demographic group (9.9 cases per 1,000), and were similar in rural and urban regions. In younger males and females, and in older males, RA prevalence estimates were lower in rural versus urban areas. Conclusions Without adjustment for error inherent in administrative databases, RA prevalence in Quebec was approximately 1%, while adjusted estimates are approximately half that. The lower prevalence in rural areas, seen for most demographic groups, may suggest either true regional variations in RA risk, or under-ascertainment of cases in rural Quebec. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Partnership for fragility bone fracture care provision and prevention program (P4Bones):study protocol for a secondary fracture prevention pragmatic controlled trial.
- Author
-
Gaboury, Isabelle, Corriveau, Hélène, Boire, Gilles, Cabana, François, Beaulieu, Marie-Claude, Dagenais, Pierre, Gosselin, Suzanne, Bogoch, Earl, Rochette, Marie, Filiatrault, Johanne, Laforest, Sophie, Jean, Sonia, Fansi, Alvine, Theriault, Diane, and Burnand, Bernard
- Subjects
BONE injuries ,MEDICAL care costs ,MEDICAL care ,OSTEOPOROSIS ,VITAMIN D deficiency - Abstract
Background: Fractures associated with bone fragility in older adults signal the potential for secondary fracture. Fragility fractures often precipitate further decline in health and loss of mobility, with high associated costs for patients, families, society and the healthcare system. Promptly initiating a coordinated, comprehensive pharmacological bone health and falls prevention program post-fracture may improve osteoporosis treatment compliance; and reduce rates of falls and secondary fractures, and associated morbidity, mortality and costs. Methods/design: This pragmatic, controlled trial at 11 hospital sites in eight regions in Quebec, Canada, will recruit community-dwelling patients over age 50 who have sustained a fragility fracture to an intervention coordinated program or to standard care, according to the site. Site study coordinators will identify and recruit 1,596 participants for each study arm. Coordinators at intervention sites will facilitate continuity of care for bone health, and arrange fall prevention programs including physical exercise. The intervention teams include medical bone specialists, primary care physicians, pharmacists, nurses, rehabilitation clinicians, and community program organizers. The primary outcome of this study is the incidence of secondary fragility fractures within an 18-month follow-up period. Secondary outcomes include initiation and compliance with bone health medication; time to first fall and number of clinically significant falls; fall-related hospitalization and mortality; physical activity; quality of life; fragility fracture-related costs; admission to a long term care facility; participants' perceptions of care integration, expectations and satisfaction with the program; and participants' compliance with the fall prevention program. Finally, professionals at intervention sites will participate in focus groups to identify barriers and facilitating factors for the integrated fragility fracture prevention program. This integrated program will facilitate knowledge translation and dissemination via the following: involvement of various collaborators during the development and set-up of the integrated program; distribution of pamphlets about osteoporosis and fall prevention strategies to primary care physicians in the intervention group and patients in the control group; participation in evaluation activities; and eventual dissemination of study results. Study/trial registration: Clinical Trial.Gov NCT01745068 Study ID number: CIHR grant # 267395 [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial.
- Author
-
Gaboury, Isabelle, Corriveau, Hélène, Boire, Gilles, Cabana, François, Beaulieu, Marie-Claude, Dagenais, Pierre, Gosselin, Suzanne, Bogoch, Earl, Rochette, Marie, Filiatrault, Johanne, Laforest, Sophie, Jean, Sonia, Fansi, Alvine, Theriault, Diane, and Burnand, Bernard
- Abstract
Background: Fractures associated with bone fragility in older adults signal the potential for secondary fracture. Fragility fractures often precipitate further decline in health and loss of mobility, with high associated costs for patients, families, society and the healthcare system. Promptly initiating a coordinated, comprehensive pharmacological bone health and falls prevention program post-fracture may improve osteoporosis treatment compliance; and reduce rates of falls and secondary fractures, and associated morbidity, mortality and costs.Methods/design: This pragmatic, controlled trial at 11 hospital sites in eight regions in Quebec, Canada, will recruit community-dwelling patients over age 50 who have sustained a fragility fracture to an intervention coordinated program or to standard care, according to the site. Site study coordinators will identify and recruit 1,596 participants for each study arm. Coordinators at intervention sites will facilitate continuity of care for bone health, and arrange fall prevention programs including physical exercise. The intervention teams include medical bone specialists, primary care physicians, pharmacists, nurses, rehabilitation clinicians, and community program organizers.The primary outcome of this study is the incidence of secondary fragility fractures within an 18-month follow-up period. Secondary outcomes include initiation and compliance with bone health medication; time to first fall and number of clinically significant falls; fall-related hospitalization and mortality; physical activity; quality of life; fragility fracture-related costs; admission to a long term care facility; participants' perceptions of care integration, expectations and satisfaction with the program; and participants' compliance with the fall prevention program. Finally, professionals at intervention sites will participate in focus groups to identify barriers and facilitating factors for the integrated fragility fracture prevention program.This integrated program will facilitate knowledge translation and dissemination via the following: involvement of various collaborators during the development and set-up of the integrated program; distribution of pamphlets about osteoporosis and fall prevention strategies to primary care physicians in the intervention group and patients in the control group; participation in evaluation activities; and eventual dissemination of study results. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.